Company intelligence / Profile preview

Phases123

New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Phases123 is a New Jersey-based consulting and advisory firm specializing in the biotechnology and pharmaceutical sectors. Founded in 2008 by Dr. Geert Cauwenbergh, the company serves as a strategic "think-tank" for private startups and small-to-medium-sized healthcare enterprises. Its services encompass organizational and business development, R&D strategy and planning, corporate and financial strategy, and investor relations. Phases123 leverages the extensive industry experience of its leadership to help emerging life science companies navigate the complexities of drug development, regulatory pathways, and commercialization.

Industry: Consulting

Beyond the preview

Go deeper on Phases123.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phases123.

Explore the full profile